Comparison between the CLL-IPI and the Barcelona-Brno prognostic model: Analysis of 1299 newly diagnosed cases.

about

The International Prognostic Index for Patients with Chronic Lymphocytic Leukemia Has the Higher Value in Predicting Overall Outcome Compared with the Barcelona-Brno Biomarkers Only Prognostic Model and the MD Anderson Cancer Center Prognostic Index

P2860

Q55077967-4DB04825-7937-4808-A862-76CEA2618CCA

P2860

Comparison between the CLL-IPI and the Barcelona-Brno prognostic model: Analysis of 1299 newly diagnosed cases.

Item

http://www.wikidata.org/entity/Q48370192

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Comparison between the CLL-IPI ...... of 1299 newly diagnosed cases.

@en

Comparison between the CLL-IPI ...... of 1299 newly diagnosed cases.

@nl

type

Item

label

Comparison between the CLL-IPI ...... of 1299 newly diagnosed cases.

@en

Comparison between the CLL-IPI ...... of 1299 newly diagnosed cases.

@nl

prefLabel

Comparison between the CLL-IPI ...... of 1299 newly diagnosed cases.

@en

Comparison between the CLL-IPI ...... of 1299 newly diagnosed cases.

@nl

P1476

Comparison between the CLL-IPI ...... of 1299 newly diagnosed cases

@en

P2093

Anna Grazia Recchia

http://www.w3.org/2001/XMLSchema#string

Davide Rossi

http://www.w3.org/2001/XMLSchema#string

Ernesto Vigna

http://www.w3.org/2001/XMLSchema#string

Fortunato Morabito

http://www.w3.org/2001/XMLSchema#string

Gianluca Gaidano

http://www.w3.org/2001/XMLSchema#string

Giovanni Tripepi

http://www.w3.org/2001/XMLSchema#string

Giuseppina Uccello

http://www.w3.org/2001/XMLSchema#string

Idanna Innocenti

http://www.w3.org/2001/XMLSchema#string

Iolanda Vincelli

http://www.w3.org/2001/XMLSchema#string

Luca Laurenti

http://www.w3.org/2001/XMLSchema#string

P2860

An international prognostic index for patients with chronic lymphocytic leukaemia (CLL-IPI): a meta-analysis of individual patient data.

Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial.

Chronic lymphocytic leukemia: A prognostic model comprising only two biomarkers (IGHV mutational status and FISH cytogenetics) separates patients with different outcome and simplifies the CLL-IPI.

Validation of the CLL-IPI and comparison with the MDACC prognostic index in newly diagnosed patients.

The chronic lymphocytic leukemia international prognostic index predicts time to first treatment in early CLL: Independent validation in a prospective cohort of early stage patients.

P304

E35-E37

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/AJH.24960

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Francesca Romana Mauro

P577

2017-11-23T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29098721

http://www.w3.org/2001/XMLSchema#string

Comparison between the CLL-IPI and the Barcelona-Brno prognostic model: Analysis of 1299 newly diagnosed cases.

about

P2860

P2860

Comparison between the CLL-IPI and the Barcelona-Brno prognostic model: Analysis of 1299 newly diagnosed cases.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698